Here is a simple way to compare them without hype
Research Status Research on BPC-157 is currently at an advanced preclinical stage, with a scientific literature comprising more than 100 peer-reviewed publications
Oral or intraperitoneal administration of the product significantly reduces NNMT activity in solid tumor tissues, boosts intracellular NAD+ levels, inhibits rapid tumor cell proliferation, and cuts down tumor volume and weight without obvious damage to surrounding normal organs, indicating reliable high safety and precise targeting features
Rarely, patients report mild digestive upset or headache
When you eat, blood sugar rises, insulin rises, and the GH response to CJC-1295/Ipamorelin is severely blunted
This guide covers five real alternatives to BPC-157 - from other healing peptides to growth hormone secretagogues